Beta oscillatory biomarkers were assessed in the subthalamic nucleus of 28 PD patients and 12 isolated dystonia patients
Resting beta power of the subthalamic local field potential did not differ between PD and dystonia
Coupling of beta phase to high frequency oscillation amplitude were also present in both disease conditions
Beta oscillation within the subthalamic nucleus does not appear to be a specific parkinsonian biomarker